Mereo BioPharma (MREO) Free Cash Flow (2023 - 2026)
Mereo BioPharma (MREO) reported Free Cash Flow of -$4.3 million for Q1 2026, up 48.35% year-over-year from -$2.9 million in Q1 2025, and up 43.87% quarter-over-quarter from -$7.7 million in Q4 2025.
Mereo BioPharma (MREO) Free Cash Flow (2023 - 2026) Analysis & Trends
Mereo BioPharma (MREO) has 4 years of Free Cash Flow data on file, last reported at -$4.3 million in Q1 2026.
- Free Cash Flow for Q1 2026 came in at -$4.3 million, up 48.35% year-over-year; the trailing twelve-month figure through Mar 2026 was -$27.0 million (up 18.79% YoY), and the FY2025 annual result was -$31.0 million, up 5.61% from the prior year.
- Free Cash Flow rose to -$4.3 million in Q1 2026 per MREO's latest filing, from -$7.7 million in the prior quarter.
- Over five years, Free Cash Flow peaked at $2.7 million in Q3 2023 and troughed at -$9.4 million in Q4 2024.
- A 4-year average of -$6.9 million and a median of -$7.7 million in 2025 frame the typical range for Free Cash Flow.
- The sharpest annual moves came in 2024 and 2026: Free Cash Flow plunged 382.78% in 2024, then jumped 48.35% in 2026.
- A 4-year view of Free Cash Flow shows it stood at -$6.8 million in 2023, then tumbled by 38.75% to -$9.4 million in 2024, then increased by 18.45% to -$7.7 million in 2025, then soared by 43.87% to -$4.3 million in 2026.
- Business Quant data shows MREO's Free Cash Flow at -$4.3 million in Q1 2026, -$7.7 million in Q4 2025, and -$7.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.29 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 63,220.27 |
| 10 | Mereo BioPharma | 252.49 Mn | 252.49 Mn | - | -4.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.31 Mn |
| Mar 31, 2026 | -4.31 Mn |
| Dec 31, 2025 | -7.68 Mn |
| Dec 31, 2025 | -7.68 Mn |
| Sep 30, 2025 | -7.31 Mn |
| Sep 30, 2025 | -7.31 Mn |
| Jun 30, 2025 | -7.65 Mn |
| Jun 30, 2025 | -7.65 Mn |
| Mar 31, 2025 | -8.35 Mn |
| Mar 31, 2025 | -8.35 Mn |
| Dec 31, 2024 | -9.42 Mn |
| Dec 31, 2024 | -9.42 Mn |
| Sep 30, 2024 | -7.52 Mn |
| Sep 30, 2024 | -7.52 Mn |
| Jun 30, 2024 | -7.90 Mn |
| Jun 30, 2024 | -7.90 Mn |
| Mar 31, 2024 | -7.99 Mn |
| Mar 31, 2024 | -7.99 Mn |
| Dec 31, 2023 | -6.79 Mn |
| Dec 31, 2023 | -6.79 Mn |